ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TELA vs MDAI // NET PROFIT MARGIN

TELA Bio Inc. (NASDAQ) VS. Spectral AI Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: TELA 4 — MDAI 3
▲ NET PROFIT MARGIN LEADER: MDAI
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TELA VS. MDAI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TELA MDAI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 67.70% 45.40% +22.30 TELA /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -19.63% — TIE /fcf-yield <GO>
Operating Margin -42.00% -43.80% +1.80 TELA /operating-margins <GO>
Net Profit Margin ACTIVE -48.30% -38.50% -9.80 MDAI /net-margins <GO>
Revenue Growth (YoY) 15.80% -33.60% +49.40 TELA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 2/9 +2.00 TELA /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.6 51.2 -7.60 MDAI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $41.5M $50.5M -$9.0M MDAI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TELA REV MDAI REV TELA GROSS % MDAI GROSS % TELA FCF MDAI FCF
FY 2025 $80.3M $19.6M 67.7% 45.4% -$28.7M -$9.9M
FY 2024 $69.3M $29.6M 67.1% 44.9% -$42.6M -$9.2M
FY 2023 $58.5M $18.1M — — -$40.9M -$13.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TELA // BETA —
MDAI // BETA —